Abeona Therapeutics (ABEO)

$7.57 0.04 (0.53%)

16:00 EDT ABEO Stock Quote Delayed 30 Minutes

ABEO Stock Earnings: Abeona Therapeutics Misses EPS for Q4 2023

By InvestorPlace Earnings Mar 19, 2024

ABEO stock results show that Abeona Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.

The 7 Most Undervalued Penny Stocks to Buy in October 2023

3 Biotech Blockbusters to Turn $5,000 Into $50,000

PXMD, GETY: The Top 5 Short Squeeze Stocks to Watch This Week

More Articles

Volume:

Previous Close -

Market Cap 207.08M

PE Ratio -37.85

EPS -0.2

Volume (Avg. Vol.) 386,264

Day's Range $7.20 - $7.69

52-Week Range $2.83 - $9.01

Dividend & Yield N/A (N/A)

ABEO Stock Predictions, Articles, and Abeona Therapeutics News

From InvestorPlace
From the Web

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Jul 5, 2022

It's time to dive into all of the latest stock market news for Tuesday morning as we go over the biggest pre-market stock movers!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Jun 10, 2022

Good morning, investors! With another day starting comes another breakdown of the biggest pre-market stock movers for Friday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Dec 17, 2021

Good morning, investor! We're in the home stretch of the week as we tackle the biggest pre-market stock movers for Friday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Dec 2, 2021

Good morning, trader! We're gearing up for another busy day of trading with the biggest pre-market stock movers for Thursday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Nov 15, 2021

Welcome back, trader! We're getting right into the thick of it this week with a look at the biggest pre-market stock movers for Monday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Sep 17, 2021

There's only one day of trading left so let's start it off right with a look at the biggest pre-market stock movers for Friday.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Jul 15, 2021

Welcome back, traders! We're taking a look at the biggest pre-market stock movers for Thursday and retail traders are a major influence.

7 Penny Stocks That May Not Be Penny Stocks For Long

By Mark Putrino, CMT Apr 21, 2021

Many penny stocks are destined for bankruptcy, but there are some that will survive. Wall Street thinks these companies are undervalued.

7 Stocks Ready to Jump Another 30% in 2018

By Matt Hogan, Founder, Finbox.io Dec 19, 2017

Here are seven momentum stocks that increased by at least 30% this year and still have another 30% upside going into 2018.

Abeona Therapeutics says CEO Seshadri buys 20K shares (NASDAQ:ABEO)

From Seeking Alpha Feb 7, 2024

Abeona Therapeutics' CEO purchases 20K shares, increasing his ownership to 528.3K shares. Recent insider trade activity involved one sale.

Abeona issues update on FDA market application for pz-cel (NASDAQ:ABEO)

From Seeking Alpha Feb 1, 2024

Abeona Therapeutics (ABEO) said that the FDA currently does not intend to hold an advisory panel meeting to discuss its Biologics License Application for its th

Abeona Therapeutics announces $50M credit facility (NASDAQ:ABEO)

From Seeking Alpha Jan 8, 2024

Abeona Therapeutics secures a $50M credit facility to fund its preparations for launch and commercialization of pz-cel for RDEB treatment in the US.

Abeona shares jump after FDA priority review for epidermolysis bullosa drug (NASDAQ:ABEO)

From Seeking Alpha Nov 27, 2023

Abeona Therapeutics' investigational drug, prademagene zamikeracel, receives priority review from the U.S.

Abeona submits FDA market application for rare skin disorder drug (ABEO)

From Seeking Alpha Sep 26, 2023

Abeona Therapeutics has filed for approval of its cell therapy EB-101 in the treatment of dystrophic epidermolysis bullosa, a rare skin disorder. Read more here.

Abeona Therapeutics (ABEO) Gets a Hold from SVB Securities

From TipRanks Nov 7, 2022

SVB Securities analyst Mani Foroohar reiterated a Hold rating on Abeona Therapeutics (ABEO – Research Report) on November 3 and set a price target of $5.00. T...

ADVERTISEMENT